Found: 157
Select item for more details and to access through your institution.
T cells remaining after intensive chemotherapy for acute myelogenous leukemia show a broad cytokine release profile including high levels of interferon-γ that can be further increased by a novel protein kinase C agonist PEP005.
- Published in:
- Cancer Immunology, Immunotherapy, 2007, v. 56, n. 6, p. 913, doi. 10.1007/s00262-006-0236-5
- By:
- Publication type:
- Article
Effects of interferon gamma on native human acute myelogenous leukaemia cells.
- Published in:
- Cancer Immunology, Immunotherapy, 2007, v. 56, n. 1, p. 13, doi. 10.1007/s00262-006-0159-1
- By:
- Publication type:
- Article
T lymphocyte chemotactic chemokines in acute myelogenous leukemia (AML): local release by native human AML blasts and systemic levels of CXCL10 (IP-10), CCL5 (RANTES) and CCL17 (TARC).
- Published in:
- Cancer Immunology, Immunotherapy, 2006, v. 55, n. 7, p. 830, doi. 10.1007/s00262-005-0080-z
- By:
- Publication type:
- Article
Immunotherapy in chronic lymphocytic leukemia.
- Published in:
- Cancer Immunology, Immunotherapy, 2006, v. 55, n. 2, p. 185, doi. 10.1007/s00262-005-0031-8
- By:
- Publication type:
- Article
Is targeted chemotherapy an alternative to immunotherapy in chronic lymphocytic leukemia?
- Published in:
- Cancer Immunology, Immunotherapy, 2006, v. 55, n. 2, p. 221, doi. 10.1007/s00262-005-0032-7
- By:
- Publication type:
- Article
Functional characterization of T lymphocytes derived from patients with acute myelogenous leukemia and chemotherapy-induced leukopenia.
- Published in:
- Cancer Immunology, Immunotherapy, 2004, v. 53, n. 8, p. 740, doi. 10.1007/s00262-004-0505-0
- By:
- Publication type:
- Article
How should clinical data be included in experimental studies of cancer immunology?
- Published in:
- Cancer Immunology, Immunotherapy, 2004, v. 53, n. 8, p. 677, doi. 10.1007/s00262-004-0515-y
- By:
- Publication type:
- Article
Human acute lymphoblastic leukemia (ALL) blasts as accessory cells during T-cell activation: differences between patients in costimulatory capacity affect proliferative responsiveness and cytokine release by activated T cells.
- Published in:
- Cancer Immunology, Immunotherapy, 2003, v. 52, n. 4, p. 215, doi. 10.1007/s00262-002-0364-5
- By:
- Publication type:
- Article
Soluble Fas/Apo-1 (CD95) levels during T cell activation in the presence of acute myelogenous leukemia accessory cells; contributions from local release and variations in systemic levels.
- Published in:
- Cancer Immunology, Immunotherapy, 2000, v. 49, n. 7, p. 377, doi. 10.1007/s002620000133
- By:
- Publication type:
- Article
Disease-stabilizing treatment with all-trans retinoic acid and valproic acid in acute myeloid leukemia: Serum hsp70 and hsp90 levels and serum cytokine profiles are determined by the disease, patient age, and anti-leukemic treatment.
- Published in:
- American Journal of Hematology, 2012, v. 87, n. 4, p. 368, doi. 10.1002/ajh.23116
- By:
- Publication type:
- Article
Effects of insulin and pathway inhibitors on the PI3K-Akt-mTOR phosphorylation profile in acute myeloid leukemia cells.
- Published in:
- Signal Transduction & Targeted Therapy, 2019, v. 4, n. 1, p. N.PAG, doi. 10.1038/s41392-019-0050-0
- By:
- Publication type:
- Article
The proliferative response of peripheral blood mononuclear cells to streptokinase.
- Published in:
- APMIS, 1990, v. 98, n. 7-12, p. 1077, doi. 10.1111/j.1699-0463.1990.tb05037.x
- By:
- Publication type:
- Article
The additive effect of certain drugs on the Cyclosporine A inhibition of human T-cell proliferation.
- Published in:
- APMIS, 1990, v. 98, n. 7-12, p. 1070, doi. 10.1111/j.1699-0463.1990.tb05036.x
- By:
- Publication type:
- Article
The Regulation of Neutrophil Migration in Patients with Sepsis: The Complexity of the Molecular Mechanisms and Their Modulation in Sepsis and the Heterogeneity of Sepsis Patients.
- Published in:
- Cells (2073-4409), 2023, v. 12, n. 7, p. 1003, doi. 10.3390/cells12071003
- By:
- Publication type:
- Article
p53 Protein Isoform Profiles in AML: Correlation with Distinct Differentiation Stages and Response to Epigenetic Differentiation Therapy.
- Published in:
- Cells (2073-4409), 2021, v. 10, n. 4, p. 833, doi. 10.3390/cells10040833
- By:
- Publication type:
- Article
Targeting Cellular Metabolism in Acute Myeloid Leukemia and the Role of Patient Heterogeneity.
- Published in:
- Cells (2073-4409), 2020, v. 9, n. 5, p. 1155, doi. 10.3390/cells9051155
- By:
- Publication type:
- Article
Systemic Metabolomic Profiling of Acute Myeloid Leukemia Patients before and During Disease-Stabilizing Treatment Based on All-Trans Retinoic Acid, Valproic Acid, and Low-Dose Chemotherapy.
- Published in:
- Cells (2073-4409), 2019, v. 8, n. 10, p. 1229, doi. 10.3390/cells8101229
- By:
- Publication type:
- Article
Bone marrow abnormalities detected by magnetic resonance imaging as initial sign of hematologic malignancies.
- Published in:
- Clinics & Practice, 2018, v. 8, n. 2, p. 63, doi. 10.4081/cp.2018.1061
- By:
- Publication type:
- Article
Microvascular endothelial cells increase proliferation and inhibit apoptosis of native human acute myelogenous leukemia blasts.
- Published in:
- International Journal of Cancer, 2006, v. 119, n. 10, p. 2313, doi. 10.1002/ijc.22180
- By:
- Publication type:
- Article
In vitro effects of native human acute myelogenous leukemia blasts on fibroblasts and osteoblasts.
- Published in:
- International Journal of Cancer, 2004, v. 111, n. 6, p. 858, doi. 10.1002/ijc.20353
- By:
- Publication type:
- Article
Serum levels of angiogenin, basic fibroblast growth factor and endostatin in patients receiving intensive chemotherapy for acute myelogenous leukemia.
- Published in:
- International Journal of Cancer, 2002, v. 101, n. 1, p. 86, doi. 10.1002/ijc.10566
- By:
- Publication type:
- Article
Effects of cytarabine and various anthracyclins on platelet activation: Characterization of in vitro effects and their possible clinical relevance in acute myelogenous leukemia.
- Published in:
- International Journal of Cancer, 2002, v. 97, n. 1, p. 106, doi. 10.1002/ijc.1566
- By:
- Publication type:
- Article
Anti-proliferative activity of the NPM1 interacting natural product avrainvillamide in acute myeloid leukemia.
- Published in:
- Cell Death & Disease, 2016, v. 7, n. 12, p. e2497, doi. 10.1038/cddis.2016.392
- By:
- Publication type:
- Article
Inhibition of Mammalian Target of Rapamycin in Human Acute Myeloid Leukemia Cells Has Diverse Effects That Depend on the Environmental In Vitro Stress.
- Published in:
- Bone Marrow Research, 2012, p. 1, doi. 10.1155/2012/329061
- By:
- Publication type:
- Article
Future Perspectives: Therapeutic Targeting of Notch SignallingMay Become a Strategy in Patients Receiving Stem Cell Transplantation for HematologicMalignancies.
- Published in:
- Bone Marrow Research, 2011, p. 1, doi. 10.1155/2011/570796
- By:
- Publication type:
- Article
Toll-like Receptor 4, Osteoblasts and Leukemogenesis; the Lesson from Acute Myeloid Leukemia.
- Published in:
- Molecules, 2022, v. 27, n. 3, p. 735, doi. 10.3390/molecules27030735
- By:
- Publication type:
- Article
Immunomodulatory Drugs Alter the Metabolism and the Extracellular Release of Soluble Mediators by Normal Monocytes.
- Published in:
- Molecules, 2020, v. 25, n. 2, p. 367, doi. 10.3390/molecules25020367
- By:
- Publication type:
- Article
CDC25 Inhibition in Acute Myeloid Leukemia-AStudy of Patient Heterogeneity and the Effects of Different Inhibitors.
- Published in:
- Molecules, 2017, v. 22, n. 3, p. 446, doi. 10.3390/molecules22030446
- By:
- Publication type:
- Article
The Complexity of Targeting PI3K-Akt-mTOR Signalling in Human Acute Myeloid Leukaemia: The Importance of Leukemic Cell Heterogeneity, Neighbouring Mesenchymal Stem Cells and Immunocompetent Cells.
- Published in:
- Molecules, 2016, v. 21, n. 11, p. 1512, doi. 10.3390/molecules21111512
- By:
- Publication type:
- Article
Therapeutic Targeting the Cell Division Cycle 25 (CDC25) Phosphatases in Human Acute Myeloid Leukemia — The Possibility to Target Several Kinases through Inhibition of the Various CDC25 Isoforms.
- Published in:
- Molecules, 2014, v. 19, n. 11, p. 18414, doi. 10.3390/molecules191118414
- By:
- Publication type:
- Article
Effects of cytarabine on activation of human T cells - cytarabine has concentration-dependent effects that are modulated both by valproic acid and all-trans retinoic acid.
- Published in:
- BMC Pharmacology & Toxicology, 2015, v. 16, n. 1, p. 1, doi. 10.1186/s40360-015-0012-2
- By:
- Publication type:
- Article
Distinct single cell signal transduction signatures in leukocyte subsets stimulated with khat extract, amphetamine-like cathinone, cathine or norephedrine.
- Published in:
- BMC Pharmacology & Toxicology, 2013, v. 14, n. 1, p. 1, doi. 10.1186/2050-6511-14-35
- By:
- Publication type:
- Article
The Cellular Immune System of Patients with Acute Leukemia and Severe Chemotherapy-Induced Leukopenia: Characterization of T Lymphocyte Subsets Responsive to IL-16 and IL-17.
- Published in:
- Acta Haematologica, 2000, v. 104, n. 2/3, p. 80, doi. 10.1159/000039756
- By:
- Publication type:
- Article
Granulocyte colony-stimulating factor alters the systemic metabolomic profile in healthy donors.
- Published in:
- Metabolomics, 2017, v. 13, n. 1, p. 1, doi. 10.1007/s11306-016-1139-x
- By:
- Publication type:
- Article
The pretransplant systemic metabolic profile reflects a risk of acute graft versus host disease after allogeneic stem cell transplantation.
- Published in:
- Metabolomics, 2016, v. 12, n. 1, p. N.PAG, doi. 10.1007/s11306-015-0880-x
- By:
- Publication type:
- Article
Proteomic Comparison of Bone Marrow Derived Osteoblasts and Mesenchymal Stem Cells.
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 11, p. 5665, doi. 10.3390/ijms22115665
- By:
- Publication type:
- Article
The Implementation of Mass Spectrometry-Based Proteomics Workflows in Clinical Routines of Acute Myeloid Leukemia: Applicability and Perspectives.
- Published in:
- International Journal of Molecular Sciences, 2020, v. 21, n. 18, p. 6830, doi. 10.3390/ijms21186830
- By:
- Publication type:
- Article
Immunological Heterogeneity of Healthy Peripheral Blood Stem Cell Donors—Effects of Granulocyte Colony-Stimulating Factor on Inflammatory Responses.
- Published in:
- International Journal of Molecular Sciences, 2018, v. 19, n. 10, p. 2886, doi. 10.3390/ijms19102886
- By:
- Publication type:
- Article
Resistance to the Antiproliferative In Vitro Effect of PI3K-Akt-mTOR Inhibition in Primary Human Acute Myeloid Leukemia Cells Is Associated with Altered Cell Metabolism.
- Published in:
- International Journal of Molecular Sciences, 2018, v. 19, n. 2, p. 382, doi. 10.3390/ijms19020382
- By:
- Publication type:
- Article
Preservation Method and Phosphate Buffered Saline Washing Affect the Acute Myeloid Leukemia Proteome.
- Published in:
- International Journal of Molecular Sciences, 2018, v. 19, n. 1, p. 296, doi. 10.3390/ijms19010296
- By:
- Publication type:
- Article
The Possible Importance of β3 Integrins for Leukemogenesis and Chemoresistance in Acute Myeloid Leukemia.
- Published in:
- International Journal of Molecular Sciences, 2018, v. 19, n. 1, p. 251, doi. 10.3390/ijms19010251
- By:
- Publication type:
- Article
Pretransplant Levels of CRP and Interleukin-6 Family Cytokines; Effects on Outcome after Allogeneic Stem Cell Transplantation.
- Published in:
- International Journal of Molecular Sciences, 2016, v. 17, n. 11, p. 1823, doi. 10.3390/ijms17111823
- By:
- Publication type:
- Article
Immunomodulation Induced by Stem Cell Mobilization and Harvesting in Healthy Donors: Increased Systemic Osteopontin Levels after Treatment with Granulocyte Colony-Stimulating Factor.
- Published in:
- International Journal of Molecular Sciences, 2016, v. 17, n. 7, p. 1158, doi. 10.3390/ijms17071158
- By:
- Publication type:
- Article
The Systemic Profile of Soluble Immune Mediators in Patients with Myelodysplastic Syndromes.
- Published in:
- International Journal of Molecular Sciences, 2016, v. 17, n. 7, p. 1080, doi. 10.3390/ijms17071080
- By:
- Publication type:
- Article
Pre-apoptotic response to therapeutic DNA damage involves protein modulation of Mcl-1, Hdm2 and Flt3 in acute myeloid leukemia cells.
- Published in:
- Molecular Cancer, 2007, v. 6, p. 33, doi. 10.1186/1476-4598-6-33
- By:
- Publication type:
- Article
LEDGF/p75 has increased expression in blasts from chemotherapy-resistant human acute myelogenic leukemia patients and protects leukemia cells from apoptosis in vitro.
- Published in:
- Molecular Cancer, 2007, v. 6, p. 1, doi. 10.1186/1476-4598-6-31
- By:
- Publication type:
- Article
Patient Heterogeneity in Acute Myeloid Leukemia: Leukemic Cell Communication by Release of Soluble Mediators and Its Effects on Mesenchymal Stem Cells.
- Published in:
- Diseases, 2021, v. 9, n. 4, p. 74, doi. 10.3390/diseases9040074
- By:
- Publication type:
- Article
Peripheral Blood Stem Cell Mobilization in Healthy Donors by Granulocyte Colony-Stimulating Factor Causes Preferential Mobilization of Lymphocyte Subsets.
- Published in:
- Frontiers in Immunology, 2018, p. 1, doi. 10.3389/fimmu.2018.00845
- By:
- Publication type:
- Article
Inflammatory Mediator Profiles Differ in Sepsis Patients With and Without Bacteremia.
- Published in:
- Frontiers in Immunology, 2018, p. 1, doi. 10.3389/fimmu.2018.00691
- By:
- Publication type:
- Article
Patients with Treatment-Requiring Chronic Graft versus Host Disease after Allogeneic Stem Cell Transplantation Have Altered Metabolic Profiles due to the Disease and Immunosuppressive Therapy: Potential Implication for Biomarkers.
- Published in:
- Frontiers in Immunology, 2018, p. 1, doi. 10.3389/fimmu.2017.01979
- By:
- Publication type:
- Article